Capvizr
THE DEAL, AT A GLANCE

Suki

From the announcement
01What happenedSuki raised $70M Series DFrom the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
02Why it mattersSuki's $70M Series D is a mid-market Healthcare & Life Sciences capital-flow signal, not an outlier round, with the deal positioned near the sector median at the 49th…From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗

Suki · Financing Record

Explore source-linked visual explanations for Suki. Unsupported claims are withheld while source review continues.

Record 2100 · Recorded date: Needs review

What it does

Unsupported business claims are withheld pending source review. Explore the linked records for available evidence.

Open record 2100 →

Explore company records →
Free weekday briefing

Know which funding rounds matter before the first call.

Source-linked rounds, lead investors, and the signal behind the capital. One five-minute read.

Free · Unsubscribe anytime